343 related articles for article (PubMed ID: 24006271)
1. Is nuchal translucency a useful aneuploidy marker in fetuses with crown-rump length of 28-44 mm?
Grande M; Solernou R; Ferrer L; Borobio V; Jimenez JM; Bennasar M; Soler A; Borrell A
Ultrasound Obstet Gynecol; 2014 May; 43(5):520-4. PubMed ID: 24006271
[TBL] [Abstract][Full Text] [Related]
2. Umbilical cord diameter at 11-14 weeks of gestation: relationship to nuchal translucency, ductus venous blood flow and chromosomal defects.
Axt-Fliedner R; Schwarze A; Kreiselmaier P; Krapp M; Smrcek J; Diedrich K
Fetal Diagn Ther; 2006; 21(4):390-5. PubMed ID: 16757918
[TBL] [Abstract][Full Text] [Related]
3. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
Zoppi MA; Ibba RM; Floris M; Monni G
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
[TBL] [Abstract][Full Text] [Related]
4. A mixture model of nuchal translucency thickness in screening for chromosomal defects.
Wright D; Kagan KO; Molina FS; Gazzoni A; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Apr; 31(4):376-83. PubMed ID: 18383462
[TBL] [Abstract][Full Text] [Related]
5. Nuchal translucency in normal fetus and its variation with increasing crown rump length (CRL) and gestational age.
Karki S; Joshi KS; Tamrakar SR; Regmi S; Khanal K
Kathmandu Univ Med J (KUMJ); 2013; 11(44):282-6. PubMed ID: 24899320
[TBL] [Abstract][Full Text] [Related]
6. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population.
Chasen ST; Sharma G; Kalish RB; Chervenak FA
Ultrasound Obstet Gynecol; 2003 Aug; 22(2):149-51. PubMed ID: 12905508
[TBL] [Abstract][Full Text] [Related]
7. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
[TBL] [Abstract][Full Text] [Related]
8. First-trimester fetal nasal bone length in an ethnic Chinese population.
Sahota DS; Leung TY; Chan LW; Law LW; Fung TY; Chan OK; Lau TK
Ultrasound Obstet Gynecol; 2009 Jul; 34(1):33-7. PubMed ID: 19424993
[TBL] [Abstract][Full Text] [Related]
9. Low-resistance hepatic artery flow in first-trimester fetuses: an ominous sign.
Bilardo CM; Timmerman E; De Medina PG; Clur SA
Ultrasound Obstet Gynecol; 2011 Apr; 37(4):438-43. PubMed ID: 20922779
[TBL] [Abstract][Full Text] [Related]
10. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
[TBL] [Abstract][Full Text] [Related]
11. Abnormal first-trimester ductus venosus blood flow: a marker of cardiac defects in fetuses with normal karyotype and nuchal translucency.
Martínez JM; Comas M; Borrell A; Bennasar M; Gómez O; Puerto B; Gratacós E
Ultrasound Obstet Gynecol; 2010 Mar; 35(3):267-72. PubMed ID: 20052662
[TBL] [Abstract][Full Text] [Related]
12. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population.
Schwärzler P; Carvalho JS; Senat MV; Masroor T; Campbell S; Ville Y
Br J Obstet Gynaecol; 1999 Oct; 106(10):1029-34. PubMed ID: 10519427
[TBL] [Abstract][Full Text] [Related]
13. Distribution of nuchal translucency thickness in Japanese fetuses.
Hasegawa J; Nakamura M; Hamada S; Matsuoka R; Ichizuka K; Sekizawa A; Okai T
J Obstet Gynaecol Res; 2013 Apr; 39(4):766-9. PubMed ID: 23107008
[TBL] [Abstract][Full Text] [Related]
14. Screening for fetal chromosomal abnormalities with nuchal translucency measurement in the first trimester.
Has R; Kalelioglu I; Ermis H; Ibrahimoglu L; Yuksel A; Yildirim A; Basaran S
Fetal Diagn Ther; 2006; 21(4):355-9. PubMed ID: 16757911
[TBL] [Abstract][Full Text] [Related]
15. Nuchal translucency and nasal bone in first-trimester ultrasound screening for aneuploidy in multiple pregnancies.
Sepulveda W; Wong AE; Casasbuenas A
Ultrasound Obstet Gynecol; 2009 Feb; 33(2):152-6. PubMed ID: 18985621
[TBL] [Abstract][Full Text] [Related]
16. Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.
Monni G; Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C
Croat Med J; 2005 Oct; 46(5):786-91. PubMed ID: 16158472
[TBL] [Abstract][Full Text] [Related]
17. Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies.
Zoppi MA; Ibba RM; Axiana C; Floris M; Manca F; Monni G
Prenat Diagn; 2003 Jun; 23(6):496-500. PubMed ID: 12813765
[TBL] [Abstract][Full Text] [Related]
18. Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13 + 6-week scan.
Faiola S; Tsoi E; Huggon IC; Allan LD; Nicolaides KH
Ultrasound Obstet Gynecol; 2005 Jul; 26(1):22-7. PubMed ID: 15937972
[TBL] [Abstract][Full Text] [Related]
19. Establishment and application of a normal range for nuchal translucency across the first trimester.
Scott F; Boogert A; Sinosich M; Anderson J
Prenat Diagn; 1996 Jul; 16(7):629-34. PubMed ID: 8843472
[TBL] [Abstract][Full Text] [Related]
20. Is Cisterna Magna Width a Useful First-Trimester Marker of Aneuploidy?
Pauta M; Grande M; Borobio V; Illanes C; Soler A; Nogué L; Borrell A
Fetal Diagn Ther; 2020; 47(6):457-463. PubMed ID: 31694020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
